SI-BONE Q3 record revenue $22.3M (+9% YoY); net loss $15.9M; FY21 guidance $89-90M

SI-BONE, Inc.

2021-Q3 EPS reported -$1.28 revenue$64,922,000

Q3 worldwide revenue $22.3M, up 9% YoY; U.S. revenue $20.4M (+8%), international $1.9M (+31%).
Gross margin improved to 89% (87% YoY); operating loss widened to $13.2M from $8.7M.
Net loss $15.9M ($0.48/sh) vs $9.5M ($0.33/sh); includes $1.8M debt extinguishment costs.
Received UnitedHealthcare exclusive iFuse coverage for SI Joint Fusion, covering ~160M U.S. lives.
FY2021 revenue guidance updated to ~$89-90M (21-23% growth); cash and securities $160.9M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.